Back to Search
PETER HWANG, MD
MD
Physical Medicine & Rehabilitation Physician
NPI: 1760639827Individual
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
125054616(IL)20120269202(MO)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
The effect of topical epinephrine 1:1000 with and without infiltration of 1% lidocaine with epinephrine 1:100,000 on endoscopic surgical field visualization: a double-blind randomized controlled study.
PMID 31671251·Int Forum Allergy Rhinol·2020
2-rct
Assessing the safety and efficacy of drugs used in preparing the nose for diagnostic and therapeutic procedures: a systematic review.
PMID 26452438·Clin Otolaryngol·2016
1-meta
Cost collection and analysis for health economic evaluation.
PMID 23641023·Otolaryngol Head Neck Surg·2013
6-review
Meta-analysis and literature review of techniques to achieve hemostasis in endoscopic sinus surgery.
PMID 23255493·Int Forum Allergy Rhinol·2013
1-meta
Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.
PMID 22147664·Laryngoscope·2012
4-observational
A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia.
PMID 21805356·Eur Arch Otorhinolaryngol·2012
8-other
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
PMID 22565282·Laryngoscope·2012
8-other
Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis.
PMID 21743869·Rhinology·2011
8-other
Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
PMID 21344445·Laryngoscope·2011
8-other
Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
PMID 21344447·Laryngoscope·2011
8-other
An epistaxis severity score for hereditary hemorrhagic telangiectasia.
PMID 20087969·Laryngoscope·2010
4-observational
The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.
PMID 19194865·Laryngoscope·2009
8-other
The hemostatic and hemodynamic effects of epinephrine during endoscopic sinus surgery: a randomized clinical trial.
PMID 19841339·Arch Otolaryngol Head Neck Surg·2009
2-rct
Epinephrine/Lidocaine injection vs. saline during endoscopic sinus surgery.
PMID 18438267·Laryngoscope·2008
4-observational
The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration.
PMID 17021315·N Engl J Med·2006
8-other
Epinephrine infiltration on nasal field causes significant hemodynamic changes: hypotension episode monitored by impedance-cardiography under general anesthesia.
PMID 16959188·J Pharm Pharm Sci·2006
2-rct
Local anesthesia for functional endoscopic sinus surgery employing small volumes of epinephrine-containing solutions of lidocaine produces profound hypotension.
PMID 16223392·Acta Anaesthesiol Scand·2005
2-rct
Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
PMID 15951295·Haematologica·2005
8-other
PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies.
PMID 19807557·Expert Rev Pharmacoecon Outcomes Res·2005
8-other
The estimation of a preference-based measure of health from the SF-12.
PMID 15319610·Med Care·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 315 BUSINESS LOOP 70 W
COLUMBIA, MO 65203 - Phone
- (573) 882-3101
Quick Facts
- NPI
- 1760639827
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile